Journal of Shanghai Jiao Tong University (Medical Science) >

2024 , Vol. 44 >Issue 4: 427 - 434

DOI: https://doi.org/10.3969/j.issn.1674-8115.2024.04.002

Basic tumor research column

SFXN3 expression in head and neck squamous cell carcinoma and its effect on cell proliferation

  • AN Junyi ,
  • CHEN Biying ,
  • CHEN Xunrui ,
  • YIN Shanshan ,
  • BIAN Zhouliang ,
  • LIU Feng
Expand
  • Department of Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201999, China
LIU Feng, E-mail: nuanliu@126.com.

Received date: 2023-11-04

  Accepted date: 2024-01-26

  Online published: 2024-04-28

Supported by

Clinical Research Promotion Program of Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine(JYLJ202019)

Fold

Abstract

Objective ·To analyze the expression of mitochondrial related gene SFXN3 (sideroflexin 3) in head and neck squamous cell carcinoma (HNSCC) and its effect on cell proliferation. Methods ·Mitochondrial related genes and TCGA-HNSCC dataset were obtained from public databases to identify the target gene SFXN3 by using bioinformatic methods. The expression of SFXN3 in HNSCC patient samples was analysed by using the UALCAN database, and survival analyses of patients with different SFXN3 expression levels were performed according to TCGA-HNSCC cohort and GEO cohorts (GSE65858, GSE41613 and GSE27020). By using TCGA-HNSCC cohort and GEO cohorts (GSE40020, GSE210287), the differences in SFXN3 expression levels between therapeutic responders and non-responders were compared. Quantitative real-time PCR (qRT-PCR) was used to verify the expression of SFXN3 in the collected HNSCC tumor and para-tumor tissues, and the expression level of SFXN3 in human normal oral epithelial cells and HNSCC tumor cell lines was detected. With the construction of stable-SFXN3-knockdown HNSCC cell lines, the effect of SFXN3 on the proliferation ability of HNSCC cells was observed by using the Incucyte live-cell imaging analysis system and plate colony formation assay. Transcriptome sequencing was performed on the total RNA of stably-SFXN3-knockdown cells and control cells, and pathway enrichment analysis was performed on the genes with differentially down-regulated expression in knockdown group compared with control group. Results ·SFXN3 was highly expressed in tumor tissues of HNSCC patients (P=0.000), and the prognosis of patients in the SFXN3-high-expression group was poor (all P<0.05). The expression level of SFXN3 in the non-responders was higher than that in the responders (P=0.008), indicating an unfavorable prognosis. High expression of SFXN3 was verified in the collected HNSCC tumor tissues and HNSCC cell lines (all P<0.05). After the knockdown of SFXN3 expression, the proliferation ability of HNSCC cells decreased, and the number of plate clones decreased (all P<0.05). RNA sequencing showed that the differentially expressed down-regulated genes in HNSCC cells in the SFXN3-knockdown group were enriched in DNA replication, cell cycle, mitochondrial translation, mitochondrial RNA metabolic process and mitochondrial gene expression pathways. Conclusion ·SFXN3 is highly expressed in HNSCC and it has negative correlation with the prognosis of patients. The proliferation ability and plate colony formation ability are inhibited in SFXN3-knockdown HNSCC cells, and these may work by affecting mitochondria function.

Key words： SFXN3; head and neck squamous cell carcinoma; mitochondria; cell proliferation

Cite this article

AN Junyi , CHEN Biying , CHEN Xunrui , YIN Shanshan , BIAN Zhouliang , LIU Feng . SFXN3 expression in head and neck squamous cell carcinoma and its effect on cell proliferation[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024 , 44(4) : 427 -434 . DOI: 10.3969/j.issn.1674-8115.2024.04.002

References

1 MODY M D, ROCCO J W, YOM S S, et al. Head and neck cancer[J]. Lancet, 2021, 398(10318): 2289-2299.
2 JOHNSON D E, BURTNESS B, LEEMANS C R, et al. Head and neck squamous cell carcinoma[J]. Nat Rev Dis Primers, 2020, 6(1): 92.
3 LEEMANS C R, BRAAKHUIS B J M, BRAKENHOFF R H. The molecular biology of head and neck cancer[J]. Nat Rev Cancer, 2011, 11(1): 9-22.
4 SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
5 KORDBACHEH F, FARAH C S. Current and emerging molecular therapies for head and neck squamous cell carcinoma[J]. Cancers, 2021, 13(21): 5471.
6 PORPORATO P E, FILIGHEDDU N, PEDRO J M B S, et al. Mitochondrial metabolism and cancer[J]. Cell Res, 2018, 28(3): 265-280.
7 CHANG J J, WU H, WU J, et al. Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma[J]. J Transl Med, 2023, 21(1): 191.
8 FERLAY J, COLOMBET M, SOERJOMATARAM I, et al. Estimating the global cancer incidence and mortality in 2018: globocan sources and methods[J]. Int J Cancer, 2019, 144(8): 1941-1953.
9 ALSAHAFI E, BEGG K, AMELIO I, et al. Clinical update on head and neck cancer: molecular biology and ongoing challenges[J]. Cell Death Dis, 2019, 10(8): 540.
10 ABATE M, FESTA A, FALCO M, et al. Mitochondria as playmakers of apoptosis, autophagy and senescence[J]. Semin Cell Dev Biol, 2020, 98: 139-153.
11 KIM H K, NOH Y H, NILIUS B, et al. Current and upcoming mitochondrial targets for cancer therapy[J]. Semin Cancer Biol, 2017, 47: 154-167.
12 FLEMING M D, CAMPAGNA D R, HASLETT J N, et al. A mutation in a mitochondrial transmembrane protein is responsible for the pleiotropic hematological and skeletal phenotype of flexed-tail (f/f) mice[J]. Genes Dev, 2001, 15(6): 652-657.
13 TIFOUN N, DE LAS HERAS J M, GUILLAUME A, et al. Insights into the roles of the sideroflexins/SLC56 family in iron homeostasis and iron-sulfur biogenesis[J]. Biomedicines, 2021, 9(2): 103.
14 KORY N, WYANT G A, PRAKASH G, et al. SFXN1 is a mitochondrial serine transporter required for one-carbon metabolism[J]. Science, 2018, 362(6416): eaat9528.
15 JIN T F, GE L Q, CHEN J Q, et al. Identification of iron metabolism-related genes as prognostic indicators for papillary thyroid carcinoma: a retrospective study[J]. PeerJ, 2023, 11: e15592.
16 MURASE R, ABE Y, TAKEUCHI T, et al. Serum autoantibody to sideroflexin 3 as a novel tumor marker for oral squamous cell carcinoma[J]. Proteomics Clin Appl, 2008, 2(4): 517-527.
17 CHEN K L, GONG S, FANG X L, et al. Non-coding RNA-mediated high expression of SFXN3 as a prognostic biomarker associated with paclitaxel resistance and immunosuppressive microenvironment in head and neck cancer[J]. Front Immunol, 2022, 13: 920136.
18 ZHENG D Y, LUO S W, WANG S, et al. Construction of a competing endogenous RNA network in head and neck squamous cell carcinoma by pan-cancer analysis[J]. Transl Cancer Res, 2022, 11(9): 3050-3063.
19 CRISCUOLO D, AVOLIO R, MATASSA D S, et al. Targeting mitochondrial protein expression as a future approach for cancer therapy[J]. Front Oncol, 2021, 11: 797265.
20 PU M, WANG J L, HUANG Q K, et al. High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes[J]. Tumour Biol, 2017, 39(7): 1010428317709127.
21 ZHU P, LIU Y Z, ZHANG F L, et al. Human elongation factor 4 regulates cancer bioenergetics by acting as a mitochondrial translation switch[J]. Cancer Res, 2018, 78(11): 2813-2824.
22 DELAUNAY S, PASCUAL G, FENG B H, et al. Mitochondrial RNA modifications shape metabolic plasticity in metastasis[J]. Nature, 2022, 607(7919): 593-603.
Options
Outlines

/

〈 〉